Trial intelligence / Profile preview

Acceptability and Safety of Paracetamol 4.8% Oral Suspension in Children

NCT00434681Phase 3Completed

Sponsor
Sanofi
Start
Oct 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of acetaminophen in fever and pain, sponsored by Sanofi. Primary endpoints: Overall evaluation of the treatment by the child's parents or the minder at 24 hours and Safety data: Events reported by the child, parents or legal guardian. Started Oct 2006; status: completed.

02

Drugs

acetaminophen
03

Conditions

feverpain

Beyond the preview

Go deeper on NCT00434681.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00434681.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call